Impaired Humoral and Cellular Responses to COVID-19 Vaccine in Heart and Lung Transplant Recipients-Reference-Cited by-同舟云学术

Impaired Humoral and Cellular Responses to COVID-19 Vaccine in Heart and Lung Transplant Recipients

Published:2022-06-15 Issue:12 Volume:205 Page:1476-1479
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Gerovasili Vicky¹²,Shah Anand¹²,Singanayagam Aran²,George Peter M.¹²,Njafuh Raymond¹,Prendecki Maria³⁴,Carby Martin¹,Willicombe Michelle³⁴,Kelleher Peter¹⁵⁶,Reed Anna¹²

Affiliation:

1. Royal Brompton and Harefield HospitalsGuy’s and St. Thomas’ National Health Service Foundation TrustLondon, United Kingdom

2. Imperial College LondonLondon, United Kingdom

3. Imperial College London, Hammersmith CampusLondon, United Kingdom

4. Hammersmith HospitalLondon, United Kingdom

5. North West London Pathology, National Health Service Foundation TrustLondon, United Kingdom

6. Imperial College London, Chelsea & Westminster Hospital CampusLondon, United Kingdom

Funder

Medical Research Council Clinical Academic Research Partnership

MRC center

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Link

https://www.atsjournals.org/doi/pdf/10.1164/rccm.202109-2026LE

Reference8 articles.

1. SARS‐CoV‐2 infection and early mortality of waitlisted and solid organ transplant recipients in England: A national cohort study

2. COVID‐19 in lung transplant recipients: A multicenter study

3. Serological Response in Lung Transplant Recipients after Two Doses of SARS-CoV-2 mRNA Vaccines

4. Efficacy of the COVID ‐19 vaccine in heart transplant recipients: what we know and what we ignore

5. Immunological responses to SARS-CoV-2 vaccines in kidney transplant recipients

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impaired immune responses and prolonged viral replication in lung allograft recipients infected with SARS-CoV-2 in the early phase after transplantation;Infection;2023-11-03

2. Third dose of BNT162b2 improves immune response in liver transplant recipients to ancestral strain but not Omicron BA.1 and XBB;Frontiers in Immunology;2023-07-03

3. Predominantly defective CD8+ T cell immunity to SARS-CoV-2 mRNA vaccination in lung transplant recipients;Journal of Translational Medicine;2023-06-08

4. Immunosuppressant and SARS-CoV-2 Vaccine Antibody Response After Lung Transplantation;Transplantation Proceedings;2022-12